Krisztina Nemenyi
General Counsel bei CYTEIR THERAPEUTICS, INC.
Aktive Positionen von Krisztina Nemenyi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYTEIR THERAPEUTICS, INC. | General Counsel | 03.05.2022 | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Karriereverlauf von Krisztina Nemenyi
Ehemalige bekannte Positionen von Krisztina Nemenyi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | - |
Ausbildung von Krisztina Nemenyi
| University of Vienna | Doctorate Degree |
| Budapest University of Technology & Economics | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Österreich | 2 |
| Ungarn | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
- Börse
- Insiders
- Krisztina Nemenyi
- Erfahrung
